Technology Transfer Tactics will be offering a webinar entitled "The Supreme Court Ruling in Helsinn v. Teva: Impact on Prior Art and Patent Eligibility for University Innovations" on March 26, 2019 from 1:00 pm to 2:00 pm (ET). Charles R. Macedo and Brian J. Amos of Amster, Rothstein and Ebenstein will discuss on-sale and public use bars, prior art rulings under both AIA and pre-AIA law, and how you can minimize risk of patent infringement and invalidity claims. The presentation will cover the following topics:
• What happened in Helsinn v. Teva, and what does it mean for on-sale bars
• What impact will Helsinn have on other types of "secret" prior art
• Best practices Technology Transfer Offices should consider to avoid adverse consequences of Helsinn
• What events to docket when entering into pre-patent application agreements
The registration fee for the webinar is $197. Those interested in registering for the webinar, can do so here.
Comments